8-K: New Era Helium Secures Up To $75 Million Equity Facility, Amends Financing Terms
Financing Agreement Update
New Era Helium Inc. has entered into a Third Amended and Restated Equity Purchase Facility Agreement, providing access to up to $75 million in equity financing while detailing terms for share issuance and debt repayment.
Summary
- New Era Helium Inc. (NEH) and an institutional investor executed a Third Amended and Restated Equity Purchase Facility Agreement (Third A&R EPFA) on July 10, 2025, superseding prior agreements from December 6, 2024, February 21, 2025, and May 5, 2025.
- The Third A&R EPFA grants NEH the right, but not the obligation, to issue and sell up to an aggregate of $75 million of common stock (Shares) to the investor.
- As of July 10, 2025, NEH had already issued 12,788,741 Shares for gross proceeds of approximately $8,588,625 under the previous agreement.
- The agreement introduces an 'Extended Purchase Pricing Period,' allowing the investor to effect sales of Shares during pre-market trading hours, and amends the definition of 'Excluded Securities.'
- NEH previously issued $10 million in senior secured convertible promissory notes to the investor, with a 7% original issue discount on pre-paid advances.
- Proceeds from the first pre-paid advance are designated for repaying up to $751,600 to Tall City Well Service Co., LP and approximately $465,000 to Solis Partners LLC, with the remainder for working capital.
- Proceeds from subsequent share sales will first be used to pay down the promissory notes, then for working capital.
- The investor received 550,000 'Incentive Shares' on or prior to the original agreement date, free from trading restrictions.
- NEH must maintain a minimum cash balance of $500,000 during the commitment period.
- The company is restricted from certain 'Variable Rate Transactions' and must apply at least 20% of net proceeds from other subsequent placements (excluding permitted indebtedness) to repay the promissory notes.
- NEH is required to obtain stockholder approval for issuing common shares exceeding 19.99% of outstanding shares and for increasing its authorized capital stock to 250,000,000,000 shares.
- Stockholders holding at least 50.01% of voting securities have entered into 'Voting Agreements' to support these proposals.
Sentiment
Score: 5
Explanation: The agreement provides crucial access to capital, which is positive for the company's operational stability and debt management. However, the terms involve significant potential for dilution to existing shareholders, including discounts on share sales and incentive shares, creating a balanced outlook.
Positives
- Secures access to a significant equity purchase facility of up to $75 million, providing flexible capital for operations and debt management.
- The company retains sole discretion over when to request advances, allowing it to manage the timing of share issuances.
- No mandatory minimum advances or non-usage fees, offering financial flexibility without penalty for non-utilization.
- The introduction of an 'Extended Purchase Pricing Period' allows for potential share sales during pre-market trading hours, which could optimize execution.
- The financing includes senior secured convertible promissory notes, providing a structured debt component.
Negatives
- The equity purchase facility and conversion of promissory notes carry significant potential for dilution to existing stockholders.
- Shares sold under the facility are at a 5% discount to the market price, and promissory notes include a 7% original issue discount, reducing the effective capital raised per share.
- The 'Floor Price' for conversions/issuances can be adjusted downwards every six months, potentially leading to greater dilution if the stock price declines.
- The investor received 550,000 'Incentive Shares' without trading restrictions, representing immediate dilution.
- Restrictions on other capital raising activities, such as 'Variable Rate Transactions,' and a requirement to use at least 20% of net proceeds from other placements to repay promissory notes, limit future financing options.
- The company is required to maintain a minimum cash balance of $500,000, which could constrain liquidity if not managed carefully.
Risks
- Significant dilution to existing stockholders due to the issuance of common shares under the equity purchase facility and conversion of promissory notes.
- Market price volatility could lead to more shares being issued for the same amount of capital, exacerbating dilution.
- Reliance on the institutional investor for capital, subject to various limitations (ownership, registration, exchange cap, volume thresholds, floor price) that could restrict access to funds.
- Risk of delisting or suspension if the company fails to comply with Nasdaq rules, particularly regarding the 19.99% Exchange Cap without timely stockholder approval.
- Failure to maintain the minimum cash balance of $500,000 or comply with other financial covenants could trigger defaults under the agreement.
- The company may experience 'Black Out Periods' during which it cannot sell shares under the registration statement, potentially impacting its ability to raise capital when needed.
- General risk of any 'Material Adverse Effect' on the company's business, properties, liabilities, operations, or financial condition.
Future Outlook
The agreement provides a flexible financing mechanism for New Era Helium to access capital as needed, with proceeds intended for working capital and debt repayment. The company plans to seek stockholder approval to increase its authorized capital stock and to authorize the issuance of shares under the facility, which will enable further equity raises and ensure compliance with Nasdaq listing rules.
Industry Context
This type of equity purchase facility, often referred to as an 'equity line' or 'at-the-market' (ATM) facility, is a common financing tool for smaller, growth-oriented companies, particularly those in capital-intensive sectors like helium exploration and production. It provides flexible access to capital without the immediate, large-scale dilution or upfront costs of a traditional underwritten offering, making it suitable for companies seeking to manage their cash flow and fund ongoing operations or strategic initiatives in a dynamic market environment.
Comparison to Industry Standards
- The terms of this equity purchase facility, including the 5% discount on share purchases and the 7% original issue discount on promissory notes, are generally within the range seen in similar 'equity line' or 'ATM' financing agreements for small-cap companies, especially those in resource or development-stage industries.
- The inclusion of 'Incentive Shares' for the investor is a common feature in such facilities, compensating the investor for providing the commitment and flexibility.
- The 'Floor Price' mechanism, subject to downward adjustment, is a typical anti-dilution protection for the investor, but it can lead to increased dilution for existing shareholders if the stock price declines significantly, a common characteristic of these agreements.
- The requirement for stockholder approval for issuances exceeding 19.99% of outstanding shares aligns with standard Nasdaq listing rules (e.g., Rule 5635(d)) for equity compensation and certain other transactions, ensuring compliance with exchange regulations.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Articles of Incorporation | Proposal to increase the number of authorized shares of capital stock of the Company to 250,000,000,000. | Upon Stockholder Approval | This change, if approved, would significantly expand the company's capacity for future equity issuances, facilitating potential financing, mergers, or acquisitions, but also enabling substantial future dilution. |
| Stockholder Approval for Share Issuance | Seeking stockholder approval for the issuance of all shares issuable under the equity purchase facility and promissory notes in compliance with Principal Market rules (specifically, exceeding the 19.99% Exchange Cap). | Upon Stockholder Approval | This approval is crucial for maintaining compliance with Nasdaq listing requirements, preventing potential delisting issues related to large share issuances, and allowing the company to fully utilize the financing facility. |
| Voting Agreements | Certain stockholders, holding at least 50.01% of the outstanding voting securities, have entered into agreements to vote all their shares in favor of the Stockholder Proposals. | On or prior to December 6, 2024 | These agreements significantly increase the likelihood of obtaining the necessary stockholder approvals for the proposed changes, streamlining the corporate governance process for the financing. |
Related Party Transactions
- Proceeds from the first Pre-Paid Advance are designated to repay up to $751,600 outstanding under a Debenture held by Tall City Well Service Co., LP and approximately $465,000 under a Beauford Acquisition Note dated December 17, 2021 with Solis Partners LLC. The document explicitly states that proceeds will not be used to repay advances/loans to executives/employees or other related party obligations not described in SEC documents.
Stakeholder Impact
- **Shareholders**: Face significant potential dilution from the issuance of new common shares under the equity facility and the conversion of promissory notes. Their ownership percentage and per-share value could decrease.
- **Creditors**: The promissory notes are senior secured, enhancing the position of the institutional investor. Specific existing creditors (Tall City Well Service Co., LP and Solis Partners LLC) will benefit from the repayment of their outstanding debts.
- **Employees/Management**: The financing provides capital for ongoing operations, which supports job security and the company's ability to execute its business plan.
- **Company Operations**: The capital infusion provides necessary working capital and funds for debt repayment, supporting the company's financial stability and ability to pursue its strategic objectives.
Next Steps
- The company will file a Current Report on Form 8-K describing the material terms of the transactions.
- The company must maintain the continuous effectiveness of a Registration Statement with the SEC to allow the investor to resell shares.
- The company will use its best efforts to continue the listing and trading of its common shares on the Principal Market (Nasdaq).
- The company is obligated to seek stockholder approval for the issuance of shares exceeding 19.99% of outstanding shares and for increasing its authorized capital stock to 250,000,000,000 shares.
- A stockholder meeting will be promptly called and held no later than 90 days following the original agreement date (December 6, 2024) to obtain the required approvals, with potential adjournments up to 365 days.
- The company must maintain a minimum cash balance of $500,000 during the commitment period.
- Proceeds from the first pre-paid advance will be used to repay specific outstanding debts and for working capital.
- Proceeds from subsequent share sales will first be used to pay down the promissory notes, then for working capital.
Key Dates
| Date | Description |
|---|---|
| 2024-01-03 | Date of the original Business Combination Agreement and Plan of Reorganization (BCA). |
| 2024-06-05 | Date of an amendment to the BCA. |
| 2024-08-08 | Date of an amendment to the BCA. |
| 2024-09-11 | Date of an amendment to the BCA. |
| 2024-09-30 | Date of an amendment to the BCA. |
| 2024-12-06 | Date of the original Equity Purchase Facility Agreement (Original Agreement) and the date by which Voting Agreements were to be entered into. |
| 2025-02-21 | Date of the First Amended and Restated Equity Purchase Facility Agreement. |
| 2025-05-05 | Date of the Second Amended and Restated Equity Purchase Facility Agreement (Existing EPFA). |
| 2025-07-10 | Date of the Third Amended and Restated Equity Purchase Facility Agreement (Third A&R EPFA) and the date of the 8-K report. As of this date, 12,788,741 shares were issued for approximately $8,588,625 under the Existing EPFA. |
| 2025-07-15 | First 'Floor Price Reset Date' for the Promissory Notes, with subsequent resets every six months thereafter. |
| 2025-10-04 | Latest date for the Stockholder Meeting to be called and held (90 days following the date of the Original Agreement). |
| 2025-10-05 | Earliest date for the Stockholder Meeting to be adjourned and reconvened if stockholder approval is not obtained. |
| 2025-12-06 | Latest date for the Stockholder Meeting to be held if adjourned (365th calendar day after the date of the Original Agreement). |
| 2028-07-10 | Approximate termination date of the agreement (first day of the next month following the 36-month anniversary of the Effective Date, assuming Effective Date is July 10, 2025). |
Recommendation
holdKeywords
Equity Purchase Facility, SEC Filing, 8-K, Dilution, Promissory Notes, Capital Raise, Financing Agreement, Common Stock, Nasdaq, New Era Helium
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.